您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
GDF-15 Recombinant Rabbit mAb (S-1012-42)

GDF-15 Recombinant Rabbit mAb (S-1012-42)

货号: S0B0926
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    GDF-15
  • 分子别名

    Growth/differentiation factor 15, Macrophage inhibitory cytokine 1 (MIC-1), NSAID-activated gene 1 protein (NAG-1), NSAID-regulated gene 1 protein (NRG-1), Placental TGF-beta, Placental bone morphogenetic protein, Prostate differentiation factor, MIC1, PDF, PLAB, PTGFB
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Secreted
  • Accession

    Q99988
  • 克隆号

    S-1012-42
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    IHC-P, WB, IP
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
WB 1:1000
IP 1:50
IHC-P 1:500
背景介绍
  • Growth differentiation factor-15 (GDF-15), also known as macrophage inhibitory cytokine-1 (MIC-1), is a member of the transforming growth factor-β (TGF-β) superfamily. It is a stress-responsive cytokine that is produced by various cell types including macrophages, vascular smooth muscle cells, cardiomyocytes, adipocytes, and endothelial cells. GDF-15 is typically expressed at low levels in most tissues but can be significantly induced under conditions of tissue injury, hypoxia, and inflammatory cytokine responses. It plays a role in various biological processes such as organ growth, differentiation, development, and cellular repair. Notably, GDF-15 has been identified as a biomarker for disease prognosis, particularly in cardiovascular diseases, cancer, and metabolic disorders. The cytokine has also been implicated in immune modulation and has been proposed as a potential target for therapeutic intervention in conditions like obesity, diabetes, and cardiovascular diseases. Its role as an immune checkpoint and its potential as a target for cancer immunotherapy are areas of active research.

  • 免疫印迹

    • WB result of GDF-15 Recombinant Rabbit mAb
      Primary antibody: GDF-15 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated HT-1080 whole cell lysate 20 µg
      Lane 2: HT-1080 treated with 200 ng/ml TPA for 24 hours whole cell lysate 20 µg
      Lane 3: HepG2 whole cell lysate 20 µg
      Lane 4: LNCaP whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 34 kDa
      Observed MW: 34 kDa

  • 免疫沉淀

    • GDF-15 Rabbit mAb at 1/50 dilution (1 µg) immunoprecipitating GDF-15 in 0.4 mg LNCaP whole cell lysate.
      Western blot was performed on the immunoprecipitate using GDF-15 Rabbit mAb at 1/1000 dilution.
      Secondary antibody (HRP) for IP was used at 1/1000 dilution.
      Lane 1: LNCaP whole cell lysate 20 µg (Input)
      Lane 2: GDF-15 Rabbit mAb IP in LNCaP whole cell lysate
      Lane 3: Rabbit monoclonal IgG IP in LNCaP whole cell lysate
      Predicted MW: 34 kDa
      Observed MW: 34 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human placenta. Anti- GDF-15 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human prostate. Anti- GDF-15 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human prostatic cancer. Anti- GDF-15 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.